147 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
ARRY Array BioPharma Inc. $14.1 $2.97B N/A
Article Searches
Jim Cramer Advises His Viewers On Array Biopharma, Chegg And PPG Industries http://feeds.benzinga.com/~r/benzinga/~3/VK-ltxnRtys/jim-cramer-advises-his-viewers-on-array-biopharma-chegg-and-ppg-industries Apr 30, 2018 -

On CNBC's "Mad Money", Jim Cramer advised his viewer to be careful with Array Biopharma Inc (NASDAQ: ARRY) because the market is taking apart the minor drug companies.

read more

JF's Core Biotech Buys #12: Updates And Introducing Our 18th Selection https://seekingalpha.com/article/4165041-jfs-core-biotech-buys-12-updates-introducing-18th-selection?source=feed Apr 24, 2018 - President Trump´s speech on drug pricing has been postponed. Continued deal activity in the biotech sector bodes well. Abeona Therapeutics announced receipt of the FDA´s RMAT (Regenerative Medicine Ad
JF's Core Biotech Buys #11: Positive News For Several Holdings, A Change To Benchmarks And Introducing Our 17th Position https://seekingalpha.com/article/4163485-jfs-core-biotech-buys-11-positive-news-several-holdings-change-benchmarks-introducing-17th?source=feed_all_articles Apr 17, 2018 - Performance of the Core Biotech Model Account is currently tracking just ahead of the IBB and XBI over the same period of time.I explain below why I´ve made the choice to use dual benchmarks instead o
JF's Core Biotech Buys #10: Incyte Disappoints, Optimism Returns To Gene Therapy And A New Position https://seekingalpha.com/article/4161978-jfs-core-biotech-buys-10-incyte-disappoints-optimism-returns-gene-therapy-new-position?source=feed Apr 10, 2018 - The rollercoaster ride in the gene therapy space (pessimism due to clinical hold/safety fears followed by optimism over Novartis acquiring AveXis) has been an interesting case study to watch. We took
By The Numbers: Best Biotech Stocks https://seekingalpha.com/article/4161156-numbers-best-biotech-stocks?source=feed Apr 05, 2018 - The biotech sector is fertile ground for tremendously profitable stocks, but many of the names in the sector are also quite risky and volatile.Since the dispersion in returns is so wide in biotech, pi
JF's Core Biotech Buys #9: Shire In Play, Volatility Continues And Capitalizing On Weakness https://seekingalpha.com/article/4160795-jfs-core-biotech-buys-9-shire-play-volatility-continues-capitalizing-weakness?source=feed_all_articles Apr 03, 2018 - The biotech sector (and overall market) continue to experience significant weakness.If Takeda successfully bids for Shire (or rival biders come in) it could provide a much-needed boost for the biotech
Arris covers Ruckus opportunity, M&A prospects at investor day https://seekingalpha.com/news/3342303-arris-covers-ruckus-opportunity-m-prospects-investor-day?source=feed_news_all Mar 28, 2018 - At the Arris (ARRS -1.6%) investor day, executives explored the new addressable market open to it after its acquisition of the Ruckus Wireless business and said for M&A it would look to ways to b
JF's Core Biotech Buys #8: Taking Advantage Of Volatility And Initiating A Position In Dynavax https://seekingalpha.com/article/4158992-jfs-core-biotech-buys-8-taking-advantage-volatility-initiating-position-dynavax?source=feed_sector_healthcare Mar 26, 2018 - Weakness in the biotech sector continues to affect many of our holdings.For long term investors weakness and volatility should be seen as an opportunity to add to favorite stocks.Novocure received som
Biotechs Approaching New Waters https://seekingalpha.com/article/4157824-biotechs-approaching-new-waters?source=feed_all_articles Mar 20, 2018 - Biotechnology stocks are approaching highs achieved in 2015, as reflected by the Nasdaq Biotech Index.New science is opening up great opportunities with boundless potential.The biotech sector also con
JF's Core Biotech Buys Edition 1 Volume 7: Updates And Taking Advantage Of Current Weakness https://seekingalpha.com/article/4157715-jfs-core-biotech-buys-edition-1-volume-7-updates-taking-advantage-current-weakness?source=feed_all_articles Mar 20, 2018 - The biotech sector has been a weak performer lately after several bits of bad news came including a clinical hold for Solid Biosciences.Hutchison China Meditech reported an encouraging update on clini

Pages: 123456789...15

<<<Page 4>